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Abstract: Understanding macrophage responses to biomaterials is crucial to the success of implanted
medical devices, tissue engineering scaffolds, and drug delivery vehicles. Cellular responses to
materials may depend synergistically on multiple surface chemistries, due to the polyvalent nature
of cell–ligand interactions. Previous work in our lab found that different surface functionalities of
chemically modified alginate could sway macrophage phenotype toward either the pro-inflammatory
or pro-angiogenic phenotype. Using these findings, this research aims to understand the relationship
between combined material surface chemistries and macrophage phenotype. Tumor necrosis factor-α
(TNF-α) secretion, nitrite production, and arginase activity were measured and used to determine the
ability of the materials to alter macrophage phenotype. Cooperative relationships between pairwise
modifications of alginate were determined by calculating synergy values for the aforementioned
molecules. Several materials appeared to improve M1 to M2 macrophage reprogramming capabilities,
giving valuable insight into the complexity of surface chemistries needed for optimal incorporation
and survival of implanted biomaterials.
Keywords: alginate; macrophage phenotype; TNF-α; synergy
1. Introduction
Macrophages are functionally diverse cells with a multitude of roles in immunity [1], disease [2],
and wound healing [1,3–5], making them an appealing target in research areas like drug delivery [6,7],
regenerative medicine [5], and biomaterial implantation [8]. In particular, they are crucial in the
initiation, propagation, and resolution stages of the foreign body response (FBR) to implanted
biomaterials [9–11]. Macrophages are important in all stages of this response due, in part, to their
plasticity and heterogeneous phenotypes. The phenotypes in which macrophages exist are best
described as a complex scale, bookended by classical and alternative activations.
Classically activated, M1, macrophages are said to be pro-inflammatory and cytotoxic [12,13].
As cells that mediate immune responses to bacterial, viral, and fungal infections, they can be activated
by microbial stimuli (lipopolysaccharides (LPS)) or interferon (IFN)-γ, which is released by activated
lymphocytes [14–16]. The inflammatory response that these stimulating factors initiate is followed by
the release of important cytotoxic molecules such as reactive nitrogen intermediates (RNIs) and tumor
necrosis factor (TNF)-α that can have an impact on the presence of tumor cells [8,13,16]. The functions
of M1 macrophages also make them important in the inflammation stages of wound healing and
the FBR, where they produce pro-inflammatory cytokines, phagocytose microorganisms near the
injury, and recruit additional inflammatory cells to the site [8,10,17–19]. Alternatively activated, M2,
macrophages are known to be pro-angiogenic and can be activated by interleukin (IL)-4 or IL-13 [20].
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The main functions of these cells include: maintaining homeostasis, tissue repair and remodeling,
as well as promoting wound healing in the resolution stage of the FBR [8]. They fulfill these roles
with the release of IL-10, vascular endothelial growth factor (VEGF), and transforming growth factor
(TGF)-β [21]. The entire spectrum of phenotypes that exists is imperative in one way or another [4,8],
but an increased presence of either M1 or M2 macrophages may be useful for specific applications.
For example, an earlier M2 macrophage presence rather than prolonged M1 presence may allow for
proper wound closure, but in cancer therapies an M1 macrophage presence rather than pro-angiogenic,
tumor associated M2 like macrophage, may lead to the elimination of cancerous cells.
With the application of wound healing and successful implant incorporation, the significance
of macrophage plasticity is made evident by examining the timeline of macrophage presence during
the FBR [8]. Macrophage phenotype is dynamic throughout the entirety of the FBR, and a balance of
phenotypes is essential for timely progression from injury to proper healing [8]. After implantation of
a biomaterial, macrophages are classically activated by proteins that have adsorbed to the material
surface [22–24]. These macrophages release pro-inflammatory cytokines that continue to attract
monocytes to the injury site leading to chronic inflammation [19]. Attempting and failing phagocytosis
of the large implant, causes the M1 macrophages to fuse into foreign body giant cells (FBGC) [25].
Chronic inflammation is only resolved with a presence of alternatively activated macrophages resulting
from phagocytosis of dying cells around the implant, or stimulation by IL-4 or IL-13, typically from
basophils [20,26,27]. M2 macrophages seek to promote wound healing in the area of the implant [11].
However, prolonged M2 macrophage activity can lead to the formation of an extensive fibrous capsule
that may negatively impact the function of the implant [28]. Finding a balance between chronic
inflammation and continued wound healing remains an issue with many biomedical implants. Using
the idea that material surface chemistries have an impact on macrophage phenotype, it may be
hypothesized that a particular material could orchestrate appropriate progression through the FBR
to avoid both chronic wound healing and complete fibrous encapsulation. This may be particularly
applicable for electrospinning coaxial fibers [29] and sensors [30], in addition to scaffolds for tissue
engineering applications [31].
Many techniques for macrophage reprogramming have been developed that focus on either the
chemical or environmental stimuli to which macrophages are exposed [14,15,32,33]. Previous work in
this lab has indicated that some chemically modified alginates may impact macrophage phenotype [9].
For example, some modifications decreased TNF-α production by M1 macrophages, which could make
them useful for decreasing the inflammatory response to a material. Other modifications appeared to
amplify the presence of M2 macrophages by showing an increased arginase/iNOS (inducible nitric
oxide synthase) ratio compared to the control. Some of the most promising materials showed decreased
TNF-α production and increased arginase/iNOS ratios for all activations of macrophages. Finally, some
indicated that even a small amount of modification may be giving the materials some permselectivity
capabilities, which could be important for applications in drug delivery and tissue engineering.
Given the complexity of biological systems and the immune system in particular, the idea that the
most effective material surface might be made up of several chemistries is reasonable [34]. However,
this can make optimal biomaterial design criteria difficult to ascertain [34]. Cellular responses to
materials are typically directed by surface protein adsorption [22], and many biological interactions,
such as protein–ligand or protein–cell interactions, are polyvalent in nature [22,35]. This suggests
a need for a material with multiple surface chemistries to more closely imitate natural interactions,
as multiple simultaneous interactions may have unique collective properties that vary from those
displayed by each component individually [35]. The synergistic effects of material properties have
typically been studied using high-throughput combinatorial approaches [36]. This logic and testing
method have similarly been employed in synergistic drug delivery, where the aim is to achieve
some synergistic therapeutic effect, reduction of dose or toxicity, and to delay or minimize drug
resistance [37–40].
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The focus of this work was to examine the synergistic effects of a few promising material surface
chemistries described above. In order to more accurately describe the phenotype of macrophages
in vitro, a newer nomenclature will be used throughout this paper that is based on the molecule
used to activate the cells, for example M(LPS) and M(IL-4) [12]. By modifying alginate with one
functional group that amplified M(IL-4) activation (ester or oxime) and one that indicated M(LPS) to
M(IL-4) macrophage reprogramming (amide or nitro), the goal was to achieve an even greater M(IL-4)
response from all macrophage phenotypes [9]. This could be useful in the proper integration of various
biomaterials. Other materials examined here combine a surface modifier that had high permeability
but low production of toxic cytokines (sulfonic acid or nitro) with one that had low permeability but
high cytokine production (ketal or epoxide) [9]. An ideal combination of modifications would have
low permeability and also cause low production of toxic cytokines. Understanding the synergistic
effects of these materials may lead to the development of a diverse library of materials that could
influence any desired macrophage phenotype.
2. Materials and Methods
Experiments were performed with a minimum of three replicates. Results were compared to
controls of unmodified alginate as well as singly modified samples in previous work [9]. All materials
were purchased from Sigma (St. Louis, MO, USA) and used as received, unless otherwise indicated.
Fresh deionized (DI) water (Milli-Q Nanopure, Thermo Scientific, Waltham, MA, USA) was used
throughout this study.
2.1. Materials
Surface modifiers [9], coupled to medium viscosity (~600–900 cps, ~250,000 MW) alginate
(MP Biomedicals, Santa Ana, CA, USA) were chosen based on the results of previous research in
this lab [9]. This included: glycidamide; tert-butyl 4 aminobutanoate (VWR, Radnor, PA, USA);
malonamide (Fisher, Pittsburgh, PA, USA); 1-amino-4-oxocyclohexane carboxylic acid ethylene ketal;
2,4-dinitro-phenyl-hydoxylamine; 3-aminobenzamide oxime; and 3-amino-1-propane sulfonic acid
(Fisher, Pittsburgh, PA, USA).
2.2. Alginate Modification
The seven different surface modifiers were combined and coupled to the medium
viscosity alginate using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC, Oakwood Chemical,
West Colombia, SC, USA) and N-hydroxysuccinimide (NHS, Thermo Scientific, Waltham, MA, USA).
These materials were modified as previously described [9] with 50 molar equivalents of modifier 1 and
50 molar equivalents of modifier 2, rather than 100 molar equivalents of one modifier.
2.3. Elemental Analysis
In order to determine the percent modification of each material, elemental analysis was performed
to obtain %C, %H and %N. Measurements were recorded in triplicate with an acetanilide calibration
standard, combustion and reduction temperatures of 925 and 640 ◦C, respectively, and a resulting
accuracy of ±0.3% for each element. All standards and reagents are from Perkin Elmer and/or
Elementar America’s Inc. (Mt. Laurel, NJ, USA). The instrument used was a PE 2100 Series II
combustion analyzer (Perkin Elmer Inc., Waltham, MA, USA).
2.4. Water Contact Angle (WCA)
Samples were prepared by creating a positively charged surface on glass microscope slides with
poly-L-lysine (PLL). This allowed for a thin, even coating of each modified alginate to be applied to
slides by crosslinking with SrCl2 (Alfa Aesar, Haverhill, MA, USA). These coated slides could then
be inverted over a container of water. An air bubble (100 µL) was deposited under the slide and
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imaged using a digital camera (Canon EOS Rebel T3i, Canon, Melville, NY, USA). Five replicates were
collected for each sample before the angle between the slide and the bubble was measured using ImageJ
(NIH, Bethesda, MD, USA) software. The final reported WCA is 180◦ minus the measured angle.
2.5. Compression Modulus
The compression modulus was measured for each sample using manual compression testing
techniques. Modified alginate pegs were made to be approximately 10× 10× 4 mm3 in size. These pegs
were placed between two microscope slides and imaged after each of various sized weights were set
on the top slide. The changing distance between the slides in each image was measured using ImageJ,
and used to generate stress-strain curves. Linear portions of these curves were used to determine the
reported compression modulus for each sample (n = 5).
2.6. Cell Culture
RAW 264.7 cells (American Type Cell Collection, ATCC, Manassas, VA, USA) were used
as a model cell line for macrophages in these experiments. Cells were cultured in complete
medium (CM, Dulbecco’s modified Eagle’s medium (DMEM, Mediatech, Inc., Manassas, VA, USA))
supplemented with 10% fetal bovine serum (FBS, Mediatech, Inc., Manassas, VA, USA), 100 U/mL
penicillin, and 100 µg/mL streptomycin) at 37 ◦C in 5% CO2. Every three to five days, the cells were
passaged using a cell scraper to detach cells and subcultured between ~6.7 × 103 and 2.7 × 104 cells/cm2.
2.7. Cell Viability
In order to test the viability of RAW 264.7 cells in contact with the combined modified alginates,
plates were seeded for MTT (methyl thiazolyldiphenyl tetrazolium, Research Products International
Corp., Mt Prospect, IL, USA) assays during passaging. For this, 24-well plates (KSE Scientific, Durham,
NC, USA) were first coated with 0.05% PLL solutions using 200 µL/well and then incubated at 37 ◦C
for 1 h. Before seeding the cells into the plate, each well was washed twice with sterile phosphate
buffered saline (PBS). The plates were seeded with 125,000 cells/cm2 in 500 µL of CM per well and
25 ng/mL IL-4 (M(IL-4)) (eBioscience Inc., San Diego, CA, USA) or 5 ug/mL LPS (M(LPS)) and the
cells were allowed to adhere for 24 h. A control set of experiments using non-activated cells was
included and referred to as naïve or M(0) cells. Alginate coatings were created by adding ~100 µL of
modified alginate to each well, allowing it to coat the bottom, and excess alginate was removed. Next,
500 µL of 0.2 M SrCl2 were used per well to crosslink the coating. This solution was left in the wells
for approximately 5 min before replacing it with clear CM. After 48 h the supernatant was removed
and saved for further testing. To each well 500 µL of clear CM was added along with 50 µL of MTT
(5 mg/mL in DI water). After a 2 h incubation at 37 ◦C, 425 µL of the solution was removed from each
well and replaced with 500 µL of dimethyl sulfoxide (DMSO). The absorbance of each plate was read
at 540 nm with a reference of 690 nm using a BioTek Synergy HT Multidetection Microplate Reader
(BioTek, Winooski, VT, USA). Positive controls for each plate were cells with no alginate samples, and
negative controls contained media, modified alginates, and activators. Experiments were performed
in quadruplicate and results are given as the mean value for each sample normalized to the positive
control ± standard deviation.
2.8. TNF-α ELISA
Measurement of TNF-α, an M1 phenotype marker, was performed using commercially available
enzyme linked immunosorbent assay (ELISA) kits (eBioscience, Inc., San Diego, CA, USA) and
performed as described by the manufacturer, using the supernatant collected during viability assays.
2.9. Urea Assay
After 48 h of incubation with the combined modified alginates, the supernatant was removed
and saved for further testing. Cells were then washed with 400 µL of PBS, and the plates were
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placed on ice for 10 min with 100 µL of cell lysis buffer (150 µL protease inhibitor cocktail (Amresco,
Solon, OH, USA) and 15 µL Triton X-100 (Acros Technologies, Elgin, IL, USA) diluted to 15 mL with
DI water) per well. The resulting lysate (25 µL) was transferred from each well to a 96-well plate
(Argos Technologies, Elgin, IL, USA) along with 25 µL of a 10 mM MnCl2 (Fisher, Pittsburgh, PA,
USA) and 50 mM Tris solution (Fisher, Pittsburgh, PA, USA). The plate was incubated for 10 min at
55 ◦C before adding 50 µL of 1 M arginine (pH 9.7) to each well and incubating at 37 ◦C for 20 h.
Arginase activity, an M2 phenotype indicator, was measured through the conversion of arginine to
urea. This was done by adding 200 µL of a 1:2 ratio of solution 1 (1.2 g o-phthaldialdehyde (Alfa Aesar,
Haverhill, MA, USA), 1 L H2O, and 500 µL HCl (Fisher, Pittsburgh, PA, USA)) and solution 2 (0.6 g
N-(naphthyl)ethylenediamine dihydrochloride (Acros Technologies, Elgin, IL, USA), 5 g boric acid
(Fisher, Pittsburgh, PA, USA), 800 mL H2O, 111 mL sulfuric acid (Fisher, Pittsburgh, PA, USA), diluted
to 1 L with H2O) [41]. The plate was read at 520 nm with a reference at 630 nm.
2.10. Griess Reagent Assay
Nitrite production, which is also indicative of an M1 phenotype, was measured from the
supernatant collected in the urea assay described above. A standard curve was created using serial
dilutions of 100 µM NaNO2 with volumes of 150 µL. To the remaining wells 150 µL of sample were
added. To the entire plate, 130 µL of DI water and 20 µL of Griess reagent (Acros Technologies,
Elgin, IL, USA) were added and allowed to incubated for 20 min. The plate was read at 448 nm with
a 690 nm reference.
2.11. Immunocytochemistry
RAW 264.7 cells were fluorescently labeled using a previously developed protocol [9]. Briefly,
cells were seeded at 100,000 cells/cm2 on clean, PLL coated glass coverslips in Petri dishes, as M(LPS),
M(IL4), or M(0) and were coated with pairwise modified alginates as described above. After 48 h
of incubation, the cells were stained for CD11c and CD206. These coverslips were imaged with
an EVOS® FLoid® Imaging Station (Life Technologies, Grand Island, NY, USA) using the red channel
(excitation/emission 586/646 nm), blue channel (390/446 nm) and the green channel (482/532 nm).
2.12. TNF-α Diffusion
To test the diffusive properties of these pairwise modified alginates, microparticles were made
using an electrostatic droplet generation technique. Using the same equipment and techniques
previously described [9], microparticles with an average diameter of 685.15 ± 14.20 µm were made
with unmodified alginate. Amino polystyrene particles, 10 mg, (Spherotech Inc., Lake Forest, IL,
USA) were also labeled with 2 mg mouse IgG (Thermo Scientific, Waltham, MA, USA) in PBS using
20 mg of EDC. These labeled polystyrene particles were encapsulated in the unmodified alginate
particles during electrostatic droplet generation using procedures developed by Kulseng et al. [42].
Approximately 200 particles were incubated with 2 mL of supernatant known to contain TNF-α.
This supernatant was collected from M(LPS) RAW 264.7 cells cultured at ~182,000 cells/cm2 after two
days of incubation. After four days of incubation with the particles, the supernatant was removed
and compared to the original TNF-α supernatant using the TNF-α ELISA described in Section 2.8 to
determine how much had diffused into the particles.
2.13. Statistics and Data Analysis
Statistical analysis was performed using JMP® statistical software (Cary, NC, USA). Statistical
significance of the mean comparisons was determined by a two-way ANOVA. Pair-wise comparisons
were analyzed with Tukey’s honest significant difference test. Differences were considered statistically
significant for p < 0.05.
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3. Results
3.1. Modification and Characterization
After the combined modification of alginate using the molecules in Figure 1, the synthesized
materials were characterized for their hydrophobicity, compression modulus and percent modification.
Elemental analysis confirmed modification with %N values being greater for the modified alginates
than unmodified (Figure 2A,B). The WCAs of the combined modified alginates fell in a range
of 39.9◦–51.2◦ (Figure 2C), compared to the range of 49.7◦–61.0◦ with the single modifications,
and 54.1◦ ± 2.0◦ for unmodified alginate(Figure 2D). This suggests the materials remained relatively
hydrophilic. The compression moduli of the combined modified alginates ranged from 12.5–30.1 kPa
(Figure 2E), which was similar to the range in compression modulus for the single modifications
(18.8–25.0 kPa), and of unmodified alginate (25.3 ± 5.4 kPa, Figure 2F).
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3.2. Cell Viability
Biomaterials must be cytocompatible for use as implantable materials. Cytotoxicity of the
combined modified alginates was measured using MTT assays. The viability of the cells was
expressed as a percentage of the positive control of cells cultured on PLL coated tissue culture plastic.
Cells exposed to all materials showed greater than 70% viability (Figure 3). This suggests minimal
cytotoxicity, especially for cells cultured under a hydrogel.
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3.3. Arginase/iNOS
Arginase activity was determined for encapsulated macrophages by exposing cell lysate to
arginine and quantifying the urea produced. Nitrites are the stable form of NO and were quantified
through a Griess reagent assay. Absolute values for both urea and Griess assays are given in
Figure 4A–D, with the pairwise modifications on the left and the single modifications on the right for
comparison. Results from these assays are given as urea: nitrite in Figure 4E,F, which corresponds
to the amount of urea produced divided by the amount of nitrite in corresponding samples. Ratio
values range from 7.12 mg/µmol with sulfonic acid/ketal to 36.2 mg/µmol with ester/nitro for
M(IL-4) macrophages. A value of 6.88 ± 3.05 mg/µmol was previously determined for M(IL-4)
macrophages in the presence of unmodified alginate [9]. M(LPS) macrophages exhibited a narrow
range of 6.20 to 14.1 mg/µmol compared to 7.52 ± 1.76 mg/µmol for unmodified alginate. Finally,
values for M(0) macrophages ranged from 4.24 mg/µmol with the oxime/nitro modification to
33.8 mg/µmol with ester/nitro. M(0) macrophages exhibited a urea:nitrite ratio of 6.91± 2.13 mg/µmol
with unmodified alginate. Higher values for these ratios indicate a stronger M2 phenotype presence,
while low values suggest a M1 phenotype. Most values seem to indicate a stronger M2 presence when
compared to unmodified alginate. Exceptions to this statement include oxime/amide and oxime/nitro
M(LPS) macrophages.
The controls for M(IL-4), M(LPS), and M(0) cells were higher than the cells exposed to the modified
and unmodified alginates with 124 ± 30.6, 13.1 ± 2.38 and 94.3 ± 29.5 mg/µmol being measured,
respectively. The urea measured for the controls was in line with the values measured for the cells
exposed to alginate samples—20.1 ± 3.25, 16.4 ± 2.97 and 6.31 ± 1.14 mg/dL for M(IL-4), M(LPS),
and M(0) cells, respectively. However, the nitrite levels were much lower for M(IL-4) and M(0) cells,
leading to a large increase in the urea:nitrite ratio. The measured nitrite levels were 1.62 ± 0.30,
12.5 ± 0.25 and 0.67 ± 0.17 µM for M(IL-4), M(LPS), and M(0) cells respectively.
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comparison. Most modifications of alginate were able to decrease the amount of TNF-α produced in 
comparison to unmodified alginate for all macrophage phenotypes. The exception to this statement 
is oxime/amide for M(0) cells. TNF-α production by M(IL-4) macrophages ranged from 1.2 to 1.6 
ng/mL with 2.8 ± 0.68 ng/mL produced under unmodified alginate. M(0) macrophages produced a 
range of TNF-α that spanned 1.8 to 3.5 ng/mL with unmodified alginate eliciting 1.9 ± 0.17 ng/mL 
TNF-α. TNF-α produced by M(LPS) cells spanned a higher range of 2.9 to 5.7 ng/mL, and on a sample-
to-sample basis, the amount of cytokine produced was most often highest for M(LPS) macrophages. 
In the presence of unmodified alginate, M(LPS) cells produced 5.0 ± 0.53 ng/mL of TNF-α. All 
modifications had statistically lower TNF-α production than unmodified alginate for M(IL-4) 
macrophages. Similar to nitrite, TNF-α secretion from M(IL-4) and M(0) cells was much lower for the 
control than for the cells in the presence of alginate. The values for the controls were 0.58 ± 0.066, 5.0 
± 0.35 and 0.39 ± 0.016 ng/mL for M(IL-4), M(LPS) and M(0) cells, respectively. 
3.5. Fluorescent Imaging 
Immunocytochemistry (ICC) fluorescent staining was used to identify the macrophage 
phenotypes resulting from culturing cells in the presence of modified alginates. CD11c, an LPS 
Figure 4. Molecules produced by polarized RAW 264.7 macrophages encapsulat ified
alginates. Alginates were layere activated macrophages and: (A,B) nitrite; (C,D) urea;
(E,F) urea:ni rite; and (G,H) TNF-α were measured for dual (A,C,E,G) and single (B,D,F,H)
modifications. Arginase activity was measured by removing the alginate layer and ysi g the cells.
n = 4. Data repr sent the m an v lue ± standard deviation. Bars with he s me letter (a–d) are not
statistically different (p < 0.05) from data points of the same activation.
3.4. TNF-α ELISA
Production of the cytotoxic cytokine TNF-α by cells exposed to modified alginates was measured
and reported in Figure 4G. Values for single modifications of alginate are included in Figure 4H for
comparison. Most modifications of alginate were able to decrease the amount of TNF-α produced in
comparison to unmodified alginate for all macrophage phenotypes. The exception to this statement
is oxime/amide for M(0) cells. TNF-α production by M(IL-4) macrophages ranged from 1.2 to
1.6 ng/mL with 2.8 ± 0.68 ng/mL produced under unmodified alginate. M(0) macrophages produced
a range of TNF-α that spanned 1.8 to 3.5 ng/mL with unmodified alginate eliciting 1.9 ± 0.17 ng/mL
TNF-α. TNF-α produced by M(LPS) cells spanned a higher range of 2.9 to 5.7 ng/mL, and on
a sample-to-sample basis, the amount of cytokine produce was most ofte highest for M(LPS)
macrophages. In t e presence of unmodified alginate, M(LPS) cells pr uced 5.0 ± 0.53 ng/mL of
TNF-α. All modifications had statistically lower TNF-α production than unmodified alginate for
M(IL-4) macrophages. Sim lar to nitrite, TNF-α secretion from M(IL-4) and M(0) cells was much
lower for the control than for the cells in the presence of alginate. Th values for the controls were
0.58 ± 0.066, 5.0 ± 0.35 and 0.39 ± 0.016 ng/mL for M(IL-4), M(LPS) and M(0) cells, respectively.
3.5. Fluorescent Imaging
Immunocytochemistry (ICC) fl orescent staining was used to identify the macrophage phenotypes
resulting from culturing cells in the presence of modified alginates. CD11c, an LPS receptor, was used
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to identify M1 macrophages and a CD206, a mannose receptor, was used to indicate an M2 macrophage
phenotype. DAPI was also used as a nuclei stain. Representative images are shown in Figure 5A,B.
These images were used to qualitatively support the results found by measuring arginase activity,
TNF-α secretion, and nitrite production. Control staining images of macrophages with activator alone
are also included in Figure 5C.
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3.6. Synergy
Nor alizing the percent odifications of each combined alginate sa ple to that of the single
modifications, we were able to determine weight fractions of each modification. Synergy was calculated
using th equation that was developed by Karande et al. [43]:
S =
mA+B
xmA + (1− x)mB (1)
where mA, mB, and mA+B are the measured values for the different modifications and x is the weight
fraction of each modification determined by elemental analysis. These values are shown for each
macrophage phenotype in Figure 6A–D. The synergy values for nitrite were nearly one for M(LPS)
cells exposed to all modifications (0.930–1.147). Synergy values were slightly more dynamic for M(IL-4)
cells, ranging from 0.578 to 1.121, and for M(0) cells, ranging from 0.218 to 1.34. For urea, all of the
synergy values for all of the macrophage activation states were near unity. This resulted in nitrite
being entirely responsible for the synergy values for urea: nitrite. Since M(LPS) cells did not have large
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variation in the synergy values for the amount of nitrite measured in the supernatant, the synergy
values were correspondingly nearly unity (0.854–1.159). Both M(IL-4) and M(0) cells yielded more
dynamic synergy values for urea: nitrite of 0.811 to 2.613 for M(IL-4) and 0.533 to 4.31 for M(0). Finally,
the synergy values for TNF-α production were in the range of 0.783–1.778 for M(IL-4) macrophages,
0.511–1.453 for M(LPS) macrophages, and 0.303–1.246 for M(0) macrophages.
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3.7. TNF-α Diffusion 
The amount of TNF-α able to diffuse into the particles was measured using an ELISA after four 
days of incubation (Figure 7A) [9]. A wide range of values were calculated for percent loading. 
Nitro/ketal did not allow any diffusion of TNF-α, while nitro/epoxide allowed 87% loading. Percent 
loading values for single modifications of alginate are included in Figure 7B for comparison. Synergy 
values for TNF-α diffusion were calculated in the range of 0 to 4.94 (Figure 7C). 
Figure 6. Synergistic indices for molecules produced by polarized RAW 264.7 macrophages: (A) nitrite;
(B) urea; (C) urea:nitrite; and (D) TNF-α for M(LPS), M(IL-4), and M(0) cells were calculated based on
previously obtained values for single modifications of alginates [9]. n = 4. Data represent the mean
value ± standard deviation. Bars with the same letter (a–d) are not statistically different (p < 0.05) from
data points of the same activation. All measured values in panel B were statistically similar.
3.7. TNF-α Diffusion
The amount of TNF-α able to diffuse into the particles was measured using an ELISA after
four days of incubation (Figure 7A) [9]. A wide range of values were calculated for percent loading.
Nitro/ketal did not allow any diffusion of TNF-α, while nitro/epoxide allowed 87% loading. Percent
loading values for single modifications of alginate are included in Figure 7B for comparison. Synergy
values for TNF-α diffusion were calculated in the range of 0 to 4.94 (Figure 7C).
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4. Discussion
Alginate is an appealing biomaterial for n ero s wound healing and tissue engineering
applications. It is a n turally occurring, relativel ensive polymer, it has low toxicity and good
biocompatibili y, and is ea ily gelled under mild condit ons with i tions [ 4]. The structure of
alginate is similar to that of the extracellular matrix in living tissues, and it provides a relatively inert
and moist microenvironment [44,45] However, the biocompatibility of alginate remains insufficiently
understood. For example, in research by Elliot et al., alginate was used to encapsulate porcine islets in
a clinical trial for diabetes treatment [46]. While the trials were mildly successful in that there were
surviving functional islets, the overall function of the implant was severely diminished by the presence
of granulation tissue that developed in response to the alginate [46]. Many aspects of the polymer
have been studied in an attempt to improve upon the biocompatibility [47–60], and some work has
been done to chemically modify alginate and study the impact this has on cell function [9,61–63].
This research focuse n co bining surface modification t study the synergistic effects of chemical
modification on cellular responses. By using materials that have been studied in the past, we have
been able to compare predicted and actual values to examine synergy of the modifications.
In this study, we aimed to find combined modifications that would improve the biocompatibility
of alginate by reprogramming macrophages towards an M2-like phenotype. Based on the equation
used to calculate synergy, values greater than one for urea:nitrite and less than one for both TNF-α and
nitrite production would be desired. These values are most important for M(LPS) macrophages as this
is the phenotype we are aiming to reprogram. M(LPS) macrophages tend to mediate the inflammatory
stages of the foreign body response to biomaterials, which we are attempting to minimize. TNF-α
production synergy values tended to be less than or equal to one for all phenotypes studied. This may
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be due, in part, to the fact the TNF-α, must diffuse through the alginate coating in order to be measured.
As Figure 7 indicates, some of these combined modifications allow little to no TNF-α diffusion through
the alginate. However, combining this information with the urea synergy values, we can determine
which modifications may be favorably shifting macrophage phenotype towards an M2-like state.
From the values presented in Figure 6, it can be determined that almost all the modifications do
not result in cooperative interactions with M(LPS) macrophages. This is particularly interesting and
somewhat surprising for TNF-α production since variable diffusion of TNF-α through the different
modifications was observed (Figure 7).
Several different observations were noticed when examining synergistic values of TNF-α
production in concert with urea:nitrite. With respect to the M(0) macrophage synergy values, sulfonic
acid/epoxide and nitro/epoxide resulted in antagonistic synergy values for TNF-α production.
Perhaps unsurprisingly, the pairwise modifications with epoxide resulted in increases in TNF-α
production synergy values for M(IL-4) cells. Epoxide was chosen for this study because it resulted in
low permeability and high TNF-α production. Sulfonic acid combinations are also able to increase
TNF-α production synergy values for M(IL-4) cells and increased urea:nitrite values. Sulfonic
acid/epoxide was also able to improve urea: nitrite values, indicating the combinations of these
modifications shifted M(0) cells towards an M2 phenotype. Ester combinations resulted in improved
urea:nitrite values and did not have an observable synergistic effect on TNF-α for M(0) cells. Future
work in examining the synergy of these materials in a dose dependent context may elucidate the
relationship of these modifications on shifting macrophage phenotypes.
By including the TNF-α diffusion study, this work also examined the changes in diffusive
properties of alginate due to combined surface modifications. Ideally, combined modifications would
result in a lower mass transport of TNF-α than in the case of single modifications. This would
be indicated by synergy values less than one. Modifications sulfonic acid/ketal, nitro/ketal,
and oxime/nitro all had values below one. Ketal lowering diffusion was expected since it was
previously observed to have low permeability for TNF-α [9]. Interestingly, when ketal was combined
with nitro or sulfonic acid, the synergy values were less than one even though nitro and sulfonic acid
were selected for their poor permselectivity towards TNF-α and low production of TNF-α. The other
modifications had relatively high synergy values, suggesting that they are not permselective towards
TNF-α, which could potentially be harmful for islet encapsulation as in Elliot et al. [46]. In that example,
tissue development surrounding the implant cut off blood supply to the encapsulated islet preventing
them from functioning properly. In this case, with increased TNF-α release, the toxic cytokine would
be able to reach the islets and impact their ability to regulate blood sugar.
5. Conclusions
Pair-wise modifications of alginate resulted in synergistic and antagonistic responses for M(IL-4),
M(LPS) and M(0) cells for both nitrite and TNF-α secretion. There was no observed advantage or
disadvantage of these modifications in terms of arginase activity. In combining the data measuring the
shifts in macrophage phenotype with that examining TNF-α diffusion through the modified alginates,
improved materials for artificial organs can be obtained. Interestingly, certain modifications appear
to influence the synergistic index for TNF-α diffusion, such as ketal, which lowered the index for
both pair-wise combinations in which it was included. This observation held for material mediated
shifts in macrophage phenotype, e.g., ester for TNF-α secretion from M(0) cells. These results further
demonstrate the importance of chemical moieties on biomaterials in achieving appropriate cellular
responses. Although this study is not conclusive, it provides valuable insight into the impact of
multiple surface modifications on macrophage phenotype. This library is also not large enough to
offer much in the way of justified reasoning for the synergistic effects of the combined modifications.
However, it provided evidence that maximum macrophage reprogramming may require a multitude of
stimuli, and further supported the findings that simply altering the surface chemistry of a biomaterial
may have a significant impact on its biocompatibility.
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